Skip to main content
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.30
-0.16 (-2.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Taysha Gene Therapies Revenue

In the year 2025, Taysha Gene Therapies had annual revenue of $9.77M with 17.28% growth. Taysha Gene Therapies had revenue of $5.49M in the quarter ending December 31, 2025, with 171.27% growth.

Revenue (ttm)
$9.77M
Revenue Growth
+17.28%
P/S Ratio
185.23
Revenue / Employee
$98,717
Employees
99
Market Cap
1.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.77M1.44M17.28%
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Harmony Biosciences Holdings 868.45M
Innoviva 411.33M
Vericel 276.26M
AnaptysBio 234.60M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Inhibrx Biosciences 1.30M
Revenue Rankings

TSHA News

More News